What is Ocular Therapeutix, Inc.'s Market Cap?

Ocular Therapeutix, Inc.'s Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s Enterprise Value?

Ocular Therapeutix, Inc.'s Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s Price / Sales?

Ocular Therapeutix, Inc.'s Price / Sales is 46.8×, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s EV / Revenue?

Ocular Therapeutix, Inc.'s EV / Revenue is 35.3×, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s EV / EBITDA?

Ocular Therapeutix, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s Revenue (TTM)?

Ocular Therapeutix, Inc.'s Revenue (TTM) is $52.1M, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s Net Income (TTM)?

Ocular Therapeutix, Inc.'s Net Income (TTM) is -$301.4M, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s EBITDA?

Ocular Therapeutix, Inc.'s EBITDA is -$308.5M, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s Diluted EPS (TTM)?

Ocular Therapeutix, Inc.'s Diluted EPS (TTM) is -1.37, based on as-reported figures from SEC (XBRL) filings.

What is Ocular Therapeutix, Inc.'s EBITDA Margin?

Ocular Therapeutix, Inc.'s EBITDA Margin is -592.6%, based on as-reported figures from SEC (XBRL) filings.

Ocular Therapeutix, Inc. (OCUL) Financial Statements

Ocular Therapeutix, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0FT93

XNAS · usd

11.09▼ 0.28 (-2.51%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close11.37

Day's Range10.40 – 11.44

52-Week Range6.23 – 16.44

Volume2.7M

Avg Volume2.6M

Share Statistics

Shares Outstanding

Employees325

ExchangeXNAS

Listed2014-07-25

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Ocular Therapeutix, Inc. (OCUL)

What is Ocular Therapeutix, Inc.'s Market Cap?: Ocular Therapeutix, Inc.'s Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s Enterprise Value?: Ocular Therapeutix, Inc.'s Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s Price / Sales?: Ocular Therapeutix, Inc.'s Price / Sales is 46.8×, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s EV / Revenue?: Ocular Therapeutix, Inc.'s EV / Revenue is 35.3×, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s EV / EBITDA?: Ocular Therapeutix, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s Revenue (TTM)?: Ocular Therapeutix, Inc.'s Revenue (TTM) is $52.1M, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s Net Income (TTM)?: Ocular Therapeutix, Inc.'s Net Income (TTM) is -$301.4M, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s EBITDA?: Ocular Therapeutix, Inc.'s EBITDA is -$308.5M, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s Diluted EPS (TTM)?: Ocular Therapeutix, Inc.'s Diluted EPS (TTM) is -1.37, based on as-reported figures from SEC (XBRL) filings.
What is Ocular Therapeutix, Inc.'s EBITDA Margin?: Ocular Therapeutix, Inc.'s EBITDA Margin is -592.6%, based on as-reported figures from SEC (XBRL) filings.